On 2025-04-14, Lexaria Bioscience Corp. (LEXX) announced earnings per share of $-0.15 for the fiscal quarter ending 2025-02-28, beating the average analyst estimate of $-0.16.
The next expected annoucement date for quarterly earnings is 2025-07-11, with an average estimated earnings per share of $-0.15 for the fiscal quarter ending 2025-05-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-04-14 | 2025-02-28 | $-0.16 | $-0.15 |
| 2025-01-10 | 2024-11-30 | $-0.12 | $-0.16 |
| 2024-11-26 | 2024-08-31 | $-0.11 | $-0.15 |
| 2024-07-12 | 2024-05-31 | $-0.09 | $-0.13 |
| 2024-04-09 | 2024-02-29 | -- | $-0.06 |
| 2024-01-12 | 2023-11-30 | -- | $-0.13 |
| 2023-11-21 | 2023-08-31 | $-0.17 | $-0.12 |
| 2023-07-14 | 2023-05-31 | $-0.25 | $-0.37 |
| 2023-04-14 | 2023-02-28 | -- | $-0.22 |
| 2023-01-17 | 2022-11-30 | -- | $-0.30 |
| 2022-11-25 | 2022-08-31 | -- | $-0.24 |
| 2022-07-14 | 2022-05-31 | $-0.28 | $-0.41 |
| 2022-04-11 | 2022-02-28 | $-0.21 | $-0.25 |
| 2022-01-14 | 2021-11-30 | -- | $-0.35 |
| 2021-07-15 | 2021-05-31 | -- | $-0.40 |
| 2021-04-14 | 2021-02-28 | -- | $-0.28 |
| 2021-01-14 | 2020-11-30 | -- | $-0.24 |
| 2020-10-14 | 2020-08-31 | -- | $-0.30 |